Hyperfine (NASDAQ:HYPR – Get Free Report) was upgraded by analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a note issued to investors on Monday, Wall Street Zen reports.
Several other research firms have also weighed in on HYPR. Loop Capital set a $2.00 price objective on shares of Hyperfine in a research report on Tuesday, October 27th. BTIG Research reiterated a “buy” rating and set a $2.00 price target on shares of Hyperfine in a report on Tuesday, September 22nd. Lucid Cap Mkts assumed coverage on shares of Hyperfine in a research report on Tuesday, October 27th. They set a “strong-buy” rating on the stock. Weiss Ratings reiterated a “sell (d-)” rating on shares of Hyperfine in a research note on Thursday, October 15th. Finally, B. Riley Financial reiterated a “buy” rating and issued a $1.60 price objective (down from $2.00) on shares of Hyperfine in a research note on Monday, August 10th. One equities research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $2.02.
Get Our Latest Report on Hyperfine
Hyperfine Price Performance
Hyperfine (NASDAQ:HYPR – Get Free Report) last posted its quarterly earnings data on Monday, November 9th. The company reported ($0.07) earnings per share for the quarter, topping the consensus estimate of ($0.08) by $0.01. The business had revenue of $5.96 million during the quarter, compared to the consensus estimate of $5.84 million. Hyperfine had a negative net margin of 156.42% and a negative return on equity of 91.18%. As a group, research analysts forecast that Hyperfine will post -0.34 EPS for the current year.
Institutional Inflows and Outflows
Several hedge funds have recently bought and sold shares of HYPR. Renaissance Technologies LLC increased its holdings in Hyperfine by 100.2% in the first quarter. Renaissance Technologies LLC now owns 730,233 shares of the company’s stock worth $789,000 after buying an additional 365,490 shares during the last quarter. Bank of New York Mellon Corp bought a new position in Hyperfine during the second quarter valued at approximately $419,000. Russell Investments Group Ltd. raised its position in Hyperfine by 7,695.4% during the third quarter. Russell Investments Group Ltd. now owns 487,994 shares of the company’s stock valued at $394,000 after acquiring an additional 481,734 shares in the last quarter. Walleye Capital LLC raised its position in Hyperfine by 3.4% during the first quarter. Walleye Capital LLC now owns 223,988 shares of the company’s stock valued at $242,000 after acquiring an additional 7,330 shares in the last quarter. Finally, Empowered Funds LLC acquired a new stake in Hyperfine in the third quarter valued at approximately $78,000. 15.03% of the stock is owned by institutional investors and hedge funds.
About Hyperfine
Hyperfine, Inc. develops portable magnetic resonance imaging (MRI) technology for brain imaging. Its Swoop system is a low-field MRI scanner designed to bring imaging to patients at the point of care, including settings where access to conventional MRI equipment may be limited. The Swoop system is designed for use near a patient’s bedside and does not require a dedicated MRI suite. The U.S. Food and Drug Administration cleared the system in 2020, marking a milestone for the use of portable MRI in clinical care.
Featured Articles
- Five stocks we like better than Hyperfine
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Receive News & Ratings for Hyperfine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hyperfine and related companies with MarketBeat.com's FREE daily email newsletter.
